{
  "Q0": "Whole Exome Sequencing (WES)",
  "Q1": "Not specified",
  "Q2": "Yes",
  "Q3": "No",
  "Q4": "No",
  "Q5": "No",
  "Q6": "No",
  "Q7": "No",
  "Q8": "Yes",
  "Q8_followup": "Chromosomal microarray (CMA)",
  "Q9": "Yes",
  "Q9_followup": "No",
  "Q10": "No",
  "Q10_followup": "Diagnostic",
  "Q11": "Not specified",
  "Q12": "No",
  "Q13": "Not specified",
  "Q14": "Not listed",
  "Q15": "No",
  "Q16": "No",
  "Q17": "The policy requires that conventional diagnostic studies, including chromosomal microarray and targeted panels, be completed before WES is considered. Submit documentation of clinical features, prior evaluations, genetic counseling, and rationale for WES. Prior authorization may be required; check plan specifics.",
  "match": false
}